ACTIFED W Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Actifed W, and what generic alternatives are available?
Actifed W is a drug marketed by Glaxosmithkline and is included in one NDA.
The generic ingredient in ACTIFED W is codeine phosphate; pseudoephedrine hydrochloride; triprolidine hydrochloride. There are nineteen drug master file entries for this compound. Additional details are available on the codeine phosphate; pseudoephedrine hydrochloride; triprolidine hydrochloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ACTIFED W?
- What are the global sales for ACTIFED W?
- What is Average Wholesale Price for ACTIFED W?
Summary for ACTIFED W
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| DailyMed Link: | ACTIFED W at DailyMed |
US Patents and Regulatory Information for ACTIFED W
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Glaxosmithkline | ACTIFED W/ CODEINE | codeine phosphate; pseudoephedrine hydrochloride; triprolidine hydrochloride | SYRUP;ORAL | 012575-003 | Apr 4, 1984 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
